Skip to main content
usedby
Search tools, companies

How Bristol Myers Squibb uses Owkin

As published on owkin.com, June 2022. Checked by usedby on Oct 9, 2026.

What happened

Bristol Myers Squibb is working with Owkin in a multi-year collaboration that applies AI to the design of its clinical trials, starting with cardiovascular diseases. The work covers endpoint definitions, patient subgroups and treatment effect estimation using covariate adjustment and external control arms.

Summary written by usedby from the source page, in English. The figures are those of Owkin and Bristol Myers Squibb, not ours.

As part of the collaboration, data from a wide network of academic medical centers and state-of-the-art machine learning techniques will be employed to enhance clinical trial design and execution with AI-powered approaches that optimize endpoint definitions, patient subgroups, and treatment effect estimation with covariate adjustment and external control arms.

From the page. owkin.com

We look forward to collaborating with Owkin to extend our applications of AI and machine learning to enhance our discovery and development programs with high-quality, diverse data from clinical and real world sources.

Venkat Sethuraman, Senior Vice President, Global Biometrics and Data Sciences, Bristol Myers Squibb. Source

What the story claims, and what we checked

What we compared with the page.

  • The passage quoted aboveCheckedCopied word for word from the page, near the name of Bristol Myers Squibb.
  • The publication dateCheckedRead from the page’s own metadata, never guessed.
  • Bristol Myers Squibb uses OwkinCheckedConfirmed line.
  • The result itselfNot checkedWe quote it; we did not measure it.

Same company, same tool or same industry.

1,700CCAD prostate cancer patients' data integratedCleveland Clinic Abu Dhabi uses Owkin. Another customer of OwkinBoehringer Ingelheim uses OwkinAnother customer of OwkinSanofi uses OwkinAnother customer of Owkin